1,272
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Quickly diagnosed and treated prepubertal Type 1 narcolepsy case

ORCID Icon, , &
Pages 227-229 | Received 04 Nov 2017, Accepted 16 Nov 2017, Published online: 30 Nov 2017

References

  • Yoss RE, Daly DD, editors. Criteria for the diagnosis of the narcoleptic syndrome. Proceedings of the Staff Meetings Mayo Clinic; 1957.
  • Ruoff C, D R. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Curr Med Res Opin. 2016;32(10):1611–1622. doi: 10.1080/03007995.2016.1208643
  • Morrish E, King MA, Smith IE, et al. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med.. 2004;5(1):37–41. doi: 10.1016/j.sleep.2003.06.002
  • Jr W L, Koepsell TD, Ton TG, et al. The epidemiology of narcolepsy. Sleep. 2007;30(1):13–26. doi: 10.1093/sleep/30.1.13
  • Partinen M, Kornum BR, Plazzi G, et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol. 2014;13(6):600–613. doi: 10.1016/S1474-4422(14)70075-4
  • Thorpy MJ. Cataplexy associated with narcolepsy. CNS Drugs. 2006;20(1):43–50. doi: 10.2165/00023210-200620010-00004
  • American Academy of Sleep Medicine. International classification of sleep disorders. Darien (IL): American Academy of Sleep Medicine; 2014.
  • Mahlios J, De la Herrán-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol. 2013;23(5):767–773. doi: 10.1016/j.conb.2013.04.013
  • Nishino S, Sakurai E, Nevsimalova S, Yoshida Y, Watanabe T, Yanai K, et al. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep. 2009;32(2):175–180. doi: 10.1093/sleep/32.2.175
  • Aran A, Lin L, Nevsimalova S, Plazzi G, Hong SC, Weiner K, et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep. 2009;32(8):979–983. doi: 10.1093/sleep/32.8.979
  • Dauvilliers, Y, Montplaisir, J, Cochen, V, Desautels, A, Einen, M, Lin, L, et al. Post-H1N1 narcolepsy-cataplexy. Sleep. 2010;33(11): 1428–1430. doi:10.1093/sleep/33.11.1428.
  • Team EE. Swedish Medical Products Agency publishes report from a case inventory study on Pandemrix vaccination and development of narcolepsy with cataplexy. Eurosurveillance. 2011;16(26):19904.
  • Okun ML, Lin L, Pelin Z, et al. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep. 2002;25(1):27–35. doi: 10.1093/sleep/25.1.27
  • Thorpy MJ, Krieger AC. Delayed diagnosis of narcolepsy: characterization and impact. Sleep Med. 2014;15(5):502–507. doi: 10.1016/j.sleep.2014.01.015
  • Carskadon MA. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 1986;9(4):519–524. doi: 10.1093/sleep/9.4.519
  • Owens J. Classification and epidemiology of childhood sleep disorders. Sleep Med Clin. 2007;2(3):353–361. doi: 10.1016/j.jsmc.2007.05.009
  • Inocente CO, Lavault S, Lecendreux M, Dauvilliers Y, Reimao R, Gustin MP, et al. Impact of obesity in children with narcolepsy. CNS Neurosci Ther. 2013;19(7):521–528. doi: 10.1111/cns.12105
  • Sullivan SS. Narcolepsy in adolescents. Adolesc Med State Art Rev. 2010;21(3):542–555, x–xi.
  • Kotagal S, Krahn LE, Slocumb N. A putative link between childhood narcolepsy and obesity. Sleep Med. 2004;5(2):147–150. doi: 10.1016/j.sleep.2003.10.006
  • Chisholm R, Brook C, Harrison G, et al. Prepubescent narcolepsy in a six year old girl. Sleep Res. 1985;15:113.
  • Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev. 2005;9(4):269–310. doi: 10.1016/j.smrv.2005.03.004
  • Abad VC, Guilleminault C. New developments in the management of narcolepsy. Nat Sci Sleep. 2017;9:39. doi: 10.2147/NSS.S103467
  • Rosenberg R, Kim AY. The AWAKEN survey: knowledge of narcolepsy among physicians and the general population. Postgrad Med. 2014;126(1):78–86. doi: 10.3810/pgm.2014.01.2727